Published in Infect Immun on February 23, 2009
Electroporation delivery of DNA vaccines: prospects for success. Curr Opin Immunol (2011) 2.25
The future of human DNA vaccines. J Biotechnol (2012) 1.18
Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system. Clin Vaccine Immunol (2010) 0.97
Evaluation of a novel non-penetrating electrode for use in DNA vaccination. PLoS One (2011) 0.96
DNA vaccines targeting heavy chain C-terminal fragments of Clostridium botulinum neurotoxin serotypes A, B, and E induce potent humoral and cellular immunity and provide protection from lethal toxin challenge. Hum Vaccin Immunother (2015) 0.81
Molecular mechanisms for enhanced DNA vaccine immunogenicity. Expert Rev Vaccines (2015) 0.79
DNA electroporation in rabbits as a method for generation of high-titer neutralizing antisera: examples of the botulinum toxins types A, B, and E. Hum Vaccin Immunother (2013) 0.75
Technical transformation of biodefense vaccines. Vaccine (2009) 0.75
Vaccines against Botulism. Toxins (Basel) (2017) 0.75
Heterologous protection against influenza by injection of DNA encoding a viral protein. Science (1993) 10.14
Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18
Genetic immunization is a simple method for eliciting an immune response. Nature (1992) 5.30
DNA vaccines: ready for prime time? Nat Rev Genet (2008) 4.10
High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci U S A (1999) 3.31
The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett (2006) 2.04
Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem Sci (2002) 1.85
Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Vaccine (2004) 1.74
Antitoxins: novel strategies to target agents of bioterrorism. Nat Rev Microbiol (2004) 1.67
Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy. J Virol (2007) 1.44
Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept. Proc Natl Acad Sci U S A (2006) 1.41
Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses. Philos Trans R Soc Lond B Biol Sci (1999) 1.39
Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene. Gene Ther (2004) 1.36
Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int Immunol (1997) 1.33
Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice. Infect Immun (2001) 1.24
Reduced immunogenicity of DNA vaccine plasmids in mixtures. Gene Ther (2004) 1.16
Non-viral gene delivery in skeletal muscle: a protein factory. Gene Ther (2003) 1.14
Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation. JAMA (2006) 1.14
Gene vaccines. Ann Intern Med (2003) 1.13
Expression of a large, nontoxic fragment of botulinum neurotoxin serotype A and its use as an immunogen. Toxicon (1995) 1.09
Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus. Vaccine (2000) 1.08
Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies. FEBS Lett (2004) 1.07
Electric pulses applied prior to intramuscular DNA vaccination greatly improve the vaccine immunogenicity. Vaccine (2006) 1.05
DNA vaccine strategies: candidates for immune modulation and immunization regimens. Methods (2003) 1.04
Growth of clostridia and preparation of their neurotoxins. Curr Top Microbiol Immunol (1995) 1.02
Electrotransfer into skeletal muscle for protein expression. Curr Gene Ther (2006) 1.00
DNA electroporation prime and protein boost strategy enhances humoral immunity of tuberculosis DNA vaccines in mice and non-human primates. Vaccine (2005) 0.99
In vivo electroporation improves immune responses to DNA vaccination in sheep. Vaccine (2004) 0.98
Type C botulism due to toxic feed affecting 52,000 farmed foxes and minks in Finland. J Clin Microbiol (2004) 0.97
Early events of electroporation-mediated intramuscular DNA vaccination potentiate Th1-directed immune responses. J Gene Med (2005) 0.94
Vaccination of mice with DNA encoding a large fragment of botulinum neurotoxin serotype A. Vaccine (2000) 0.93
DNA vaccination protects against botulinum neurotoxin type F. Vaccine (2003) 0.92
Electric pulses increase the immunogenicity of an influenza DNA vaccine injected intramuscularly in the mouse. Vaccine (2001) 0.91
DNA transfection of mononuclear cells in muscle tissue. J Gene Med (2003) 0.91
High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle. Mol Ther (2000) 0.90
Efficacy of DNA vaccines expressing the type F botulinum toxin Hc fragment using different promoters. Vaccine (2004) 0.90
Development of venom toxin-specific antibodies by DNA immunisation: rationale and strategies to improve therapy of viper envenoming. Vaccine (2004) 0.89
DNA vaccination using the fragment C of botulinum neurotoxin type A provided protective immunity in mice. J Biomed Sci (2000) 0.88
Botulinum toxin: from life-threatening disease to novel medical therapy. Am J Obstet Gynecol (2007) 0.88
DNA immunization with Onchocerca volvulus genes, Ov-tmy-1 and OvB20: serological and parasitological outcomes following intramuscular or GeneGun delivery in a mouse model of onchocerciasis. Parasite Immunol (2000) 0.87
Production of vaccines against leading biowarfare toxins can utilize DNA scientific technology. Adv Drug Deliv Rev (2005) 0.86
Intracellular retention of hepatitis B virus surface proteins reduces interleukin-2 augmentation after genetic immunizations. J Virol (1999) 0.84
The efficacy of electroporated plasmid vaccines correlates with long-term antigen production in vivo. Vaccine (2004) 0.84
The prophylactic effect of immunization with DNA encoding herpes simplex virus glycoproteins on HSV-induced disease in guinea pigs. Vaccine (1997) 0.84
Lipopolythioureas: a new non-cationic system for gene transfer. Bioconjug Chem (2007) 0.82
Skeletal muscle as an artificial endocrine tissue. Best Pract Res Clin Endocrinol Metab (2003) 0.80
Widespread lipoplex-mediated gene transfer to vascular endothelial cells and hemangioblasts in the vertebrate embryo. Dev Dyn (2006) 0.80
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A (1995) 18.16
The mammalian G protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells. EMBO J (1989) 4.21
High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci U S A (1999) 3.31
Protective role of interleukin-10 in atherosclerosis. Circ Res (1999) 3.28
Clostridium perfringens: toxinotype and genotype. Trends Microbiol (1999) 3.21
Functional modification of a 21-kilodalton G protein when ADP-ribosylated by exoenzyme C3 of Clostridium botulinum. Mol Cell Biol (1988) 3.11
Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun (1997) 2.42
Polymerase chain reaction assay for diagnosis of potentially toxinogenic Corynebacterium diphtheriae strains: correlation with ADP-ribosylation activity assay. J Clin Microbiol (1993) 2.14
Identification and characterization of a germination operon on the virulence plasmid pXO1 of Bacillus anthracis. Mol Microbiol (1999) 2.12
Clostridium difficile toxin B acts on the GTP-binding protein Rho. J Biol Chem (1994) 2.09
Characterization of Clostridium perfringens iota-toxin genes and expression in Escherichia coli. Infect Immun (1993) 1.99
Beta2 toxin, a novel toxin produced by Clostridium perfringens. Gene (1997) 1.93
Phosphoramidate oligonucleotides as potent antisense molecules in cells and in vivo. Nat Biotechnol (2001) 1.91
Nucleotide sequence of Clostridium botulinum C1 neurotoxin. Nucleic Acids Res (1990) 1.74
Purification and characterization of Clostridium sordellii lethal toxin and cross-reactivity with Clostridium difficile cytotoxin. Infect Immun (1987) 1.72
Sequences of the botulinal neurotoxin E derived from Clostridium botulinum type E (strain Beluga) and Clostridium butyricum (strains ATCC 43181 and ATCC 43755). Biochem Biophys Res Commun (1992) 1.62
Association of the GTP-binding protein Rab3A with bovine adrenal chromaffin granules. Proc Natl Acad Sci U S A (1990) 1.58
Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Circ Res (2000) 1.55
A new DNA vehicle for nonviral gene delivery: supercoiled minicircle. Gene Ther (1997) 1.53
Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res (1999) 1.38
Constitutive production of interleukin-6 and immunologic features in cardiac myxomas. Arthritis Rheum (1990) 1.32
Pilus-mediated adhesion of Neisseria meningitidis: the essential role of cell contact-dependent transcriptional upregulation of the PilC1 protein. Mol Microbiol (1998) 1.32
Anxiety, antisocial behavior, and heart rate regulation in adolescent males. J Child Psychol Psychiatry (1997) 1.31
A chimeric toxin to study the role of the 21 kDa GTP binding protein rho in the control of actin microfilament assembly. EMBO J (1993) 1.31
Intimate adhesion of Neisseria meningitidis to human epithelial cells is under the control of the crgA gene, a novel LysR-type transcriptional regulator. EMBO J (2000) 1.30
Virus-sized self-assembling lamellar complexes between plasmid DNA and cationic micelles promote gene transfer. Proc Natl Acad Sci U S A (1997) 1.29
Evidence that Arg-295, Glu-378, and Glu-380 are active-site residues of the ADP-ribosyltransferase activity of iota toxin. FEBS Lett (1996) 1.28
Oxonol-V as a probe of chromaffin granule membrane potentials. Biochim Biophys Acta (1980) 1.28
Reserpine binding to bovine chromaffin granule membranes. Characterization and comparison with dihydrotetrabenazine binding. Mol Pharmacol (1984) 1.28
High frequency-induced upregulation of human cardiac calcium currents. Circulation (1996) 1.28
The small GTP-binding protein Rho1p is localized on the Golgi apparatus and post-Golgi vesicles in Saccharomyces cerevisiae. J Cell Biol (1991) 1.26
Nucleotide sequence of the gene encoding Clostridium botulinum neurotoxin type D. Nucleic Acids Res (1990) 1.26
Identification and characterization of functional subunits of Clostridium botulinum type A progenitor toxin involved in binding to intestinal microvilli and erythrocytes. FEBS Lett (2000) 1.26
Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex. J Bacteriol (1997) 1.26
botR/A is a positive regulator of botulinum neurotoxin and associated non-toxin protein genes in Clostridium botulinum A. Mol Microbiol (1998) 1.25
Characterization of the monoamine carrier of chromaffin granule membrane by binding of [2-3H]dihydrotetrabenazine. Proc Natl Acad Sci U S A (1983) 1.21
Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles. Biochem Pharmacol (1989) 1.21
TetR is a positive regulator of the tetanus toxin gene in Clostridium tetani and is homologous to botR. Infect Immun (1998) 1.20
Detection of the beta2 toxin gene of Clostridium perfringens in diarrhoeic piglets in The Netherlands and Switzerland. FEMS Immunol Med Microbiol (1999) 1.20
Organization of the botulinum neurotoxin C1 gene and its associated non-toxic protein genes in Clostridium botulinum C 468. Mol Gen Genet (1994) 1.19
Passive stiffness of the lumbar torso in flexion, extension, lateral bending, and axial rotation. Effect of belt wearing and breath holding. Spine (Phila Pa 1976) (1994) 1.16
Clostridium perfringens epsilon toxin induces a rapid change of cell membrane permeability to ions and forms channels in artificial lipid bilayers. J Biol Chem (2001) 1.15
Coupling of nuclear localization signals to plasmid DNA and specific interaction of the conjugates with importin alpha. Bioconjug Chem (1999) 1.14
Minicircle: an improved DNA molecule for in vitro and in vivo gene transfer. Gene Ther (1999) 1.14
pCOR: a new design of plasmid vectors for nonviral gene therapy. Gene Ther (1999) 1.13
Clostridium orbiscindens sp. nov., a human intestinal bacterium capable of cleaving the flavonoid C-ring. Int J Syst Bacteriol (1991) 1.13
Synthesis, activity, and structure--activity relationship studies of novel cationic lipids for DNA transfer. J Med Chem (1998) 1.13
Transient expression of RhoA, -B, and -C GTPases in HeLa cells potentiates resistance to Clostridium difficile toxins A and B but not to Clostridium sordellii lethal toxin. Infect Immun (1995) 1.11
PCR and gene probe identification of botulinum neurotoxin A-, B-, E-, F-, and G-producing Clostridium spp. and evaluation in food samples. Appl Environ Microbiol (1995) 1.11
Polymerase chain reaction for the rapid identification of Clostridium botulinum type A strains and detection in food samples. J Appl Bacteriol (1993) 1.10
A comparative biochemical, pharmacological and immunological study of Clostridium novyi alpha-toxin, C. difficile toxin B and C. sordellii lethal toxin. Toxicon (1991) 1.10
Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles. Gene Ther (2007) 1.08
Structural characteristics of supramolecular assemblies formed by guanidinium-cholesterol reagents for gene transfection. Proc Natl Acad Sci U S A (1999) 1.08
Immunological and functional comparison between Clostridium perfringens iota toxin, C. spiroforme toxin, and anthrax toxins. FEMS Microbiol Lett (1997) 1.08
Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta (2000) 1.08
Long-term, high level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle. C R Acad Sci III (1998) 1.07
Neonatal total parenteral nutrition ascites from liver erosion by umbilical vein catheters. Pediatr Radiol (1998) 1.07
Bacterial toxins modifying the actin cytoskeleton. Int Microbiol (1999) 1.07
Cardiac operations in octogenarians: perioperative risk factors for death and impaired autonomy. Ann Thorac Surg (1998) 1.06
Clostridium perfringens urease genes are plasmid borne. Infect Immun (1997) 1.06
Inhibition of DNA methyltransferase inhibits DNA replication. J Biol Chem (2000) 1.06
Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes. Biochim Biophys Acta (1998) 1.05
Inferring maps of forces inside cell membrane microdomains. Phys Rev Lett (2009) 1.05
Identification of Clostridium butyricum and Clostridium beijerinckii by gas-liquid chromatography and sugar fermentation: correlation with DNA homologies and electrophoretic patterns. J Gen Microbiol (1983) 1.04
Clostridium perfringens iota toxin: binding studies and characterization of cell surface receptor by fluorescence-activated cytometry. Infect Immun (2000) 1.04
Serotonin increases calcium current in human atrial myocytes via the newly described 5-hydroxytryptamine4 receptors. Mol Pharmacol (1992) 1.04
Clostridium perfringens iota-toxin requires activation of both binding and enzymatic components for cytopathic activity. Infect Immun (2000) 1.03
Clostridium perfringens iota-toxin: mapping of receptor binding and Ia docking domains on Ib. Infect Immun (2001) 1.02
Inflammation-inducible anti-TNF gene expression mediated by intra-articular injection of serotype 5 adeno-associated virus reduces arthritis. J Gene Med (2007) 1.02
Reducible cationic lipids for gene transfer. Biochem J (2001) 1.02
Electrotransfer into skeletal muscle for protein expression. Curr Gene Ther (2006) 1.00
Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent. Ann Rheum Dis (2007) 0.98
Critical assessment of the nuclear import of plasmid during cationic lipid-mediated gene transfer. J Gene Med (2001) 0.98
Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers. Biochem Pharmacol (1994) 0.97
Taxonomic position of lecithinase-negative strains of Clostridium sordellii. J Gen Microbiol (1985) 0.97
High lipophilicity decreases drug transport across intestinal epithelial cells. J Pharmacol Exp Ther (1994) 0.97
Reduction-sensitive lipopolyamines as a novel nonviral gene delivery system for modulated release of DNA with improved transgene expression. J Med Chem (2000) 0.96
Efficient purification of plasmid DNA for gene transfer using triple-helix affinity chromatography. Gene Ther (1997) 0.96
Detection of enterotoxigenic Clostridium perfringens in food and fecal samples with a duplex PCR and the slide latex agglutination test. Appl Environ Microbiol (1997) 0.96
Cationic lipid-mediated gene transfer: analysis of cellular uptake and nuclear import of plasmid DNA. Cell Biol Toxicol (1998) 0.96
Tetrodotoxin-sensitive Ca2+ and Ba2+ currents in human atrial cells. Receptors Channels (1995) 0.95
Plasmid localization of a type E botulinal neurotoxin gene homologue in toxigenic Clostridium butyricum strains, and absence of this gene in non-toxigenic C. butyricum strains. FEMS Microbiol Lett (1992) 0.95
Experimental cecitis in gnotoxenic chickens monoassociated with Clostridium butyricum strains isolated from patients with neonatal necrotizing enterocolitis. Infect Immun (1985) 0.95
Erythropoietin secretion and physiological effect in mouse after intramuscular plasmid DNA electrotransfer. J Gene Med (2000) 0.94
Pore-forming epsilon toxin causes membrane permeabilization and rapid ATP depletion-mediated cell death in renal collecting duct cells. Am J Physiol Renal Physiol (2007) 0.94
Lipospermine-based gene transfer into the newborn mouse brain is optimized by a low lipospermine/DNA charge ratio. Hum Gene Ther (1995) 0.94
Identification of initiation sites for DNA replication in the human dnmt1 (DNA-methyltransferase) locus. J Biol Chem (1999) 0.93
Synaptin/synaptophysin, p65 and SV2: their presence in adrenal chromaffin granules and sympathetic large dense core vesicles. Biochim Biophys Acta (1991) 0.92
Reserpine binding to chromaffin granules suggests the existence of two conformations of the monoamine transporter. Biochemistry (1989) 0.92
Optical imaging of luminescence for in vivo quantification of gene electrotransfer in mouse muscle and knee. BMC Biotechnol (2006) 0.92
Formulations which increase the size of lipoplexes prevent serum-associated inhibition of transfection. J Gene Med (2000) 0.92
Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models. Cancer Gene Ther (2010) 0.92
Effect of drugs on the ATP-induced and pH-gradient-driven monoamine transport by bovine chromaffin granules. Biochem Pharmacol (1980) 0.92
Electric pulses increase the immunogenicity of an influenza DNA vaccine injected intramuscularly in the mouse. Vaccine (2001) 0.91